BNP Paribas Financial Markets raised its holdings in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 13.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,607,446 shares of the company's stock after buying an additional 434,158 shares during the quarter. BNP Paribas Financial Markets owned approximately 0.27% of Keurig Dr Pepper worth $123,447,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Commerce Bank grew its holdings in Keurig Dr Pepper by 1.6% in the 1st quarter. Commerce Bank now owns 21,513 shares of the company's stock valued at $736,000 after buying an additional 340 shares during the period. First American Bank grew its holdings in Keurig Dr Pepper by 0.6% in the 1st quarter. First American Bank now owns 59,564 shares of the company's stock valued at $2,038,000 after buying an additional 344 shares during the period. Allworth Financial LP grew its holdings in shares of Keurig Dr Pepper by 3.8% during the 1st quarter. Allworth Financial LP now owns 10,242 shares of the company's stock worth $353,000 after purchasing an additional 371 shares during the period. Citadel Investment Advisory Inc. grew its holdings in shares of Keurig Dr Pepper by 6.6% during the 1st quarter. Citadel Investment Advisory Inc. now owns 6,445 shares of the company's stock worth $221,000 after purchasing an additional 400 shares during the period. Finally, Hartford Funds Management Co LLC grew its holdings in shares of Keurig Dr Pepper by 1.2% during the 1st quarter. Hartford Funds Management Co LLC now owns 34,497 shares of the company's stock worth $1,180,000 after purchasing an additional 413 shares during the period. Hedge funds and other institutional investors own 93.99% of the company's stock.
Keurig Dr Pepper Stock Down 0.6%
Shares of KDP traded down $0.18 during trading on Tuesday, reaching $28.91. The company's stock had a trading volume of 29,138,360 shares, compared to its average volume of 12,728,146. The company has a fifty day moving average of $33.27 and a two-hundred day moving average of $33.59. Keurig Dr Pepper, Inc has a twelve month low of $28.60 and a twelve month high of $38.28. The company has a market cap of $39.27 billion, a price-to-earnings ratio of 25.81, a P/E/G ratio of 1.59 and a beta of 0.47. The company has a quick ratio of 0.40, a current ratio of 0.64 and a debt-to-equity ratio of 0.56.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last announced its earnings results on Thursday, July 24th. The company reported $0.49 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.49. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The company had revenue of $4.16 billion for the quarter, compared to analyst estimates of $4.14 billion. During the same period in the prior year, the company posted $0.45 EPS. Keurig Dr Pepper's quarterly revenue was up 6.1% on a year-over-year basis. On average, sell-side analysts predict that Keurig Dr Pepper, Inc will post 1.92 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on KDP shares. Jefferies Financial Group set a $41.00 target price on Keurig Dr Pepper in a report on Monday, August 25th. UBS Group decreased their target price on Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating for the company in a report on Wednesday, August 27th. Hsbc Global Res cut Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a report on Tuesday, August 26th. JPMorgan Chase & Co. decreased their target price on Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating for the company in a report on Thursday, July 17th. Finally, HSBC reiterated a "hold" rating and set a $30.00 target price (down previously from $42.00) on shares of Keurig Dr Pepper in a report on Tuesday, August 26th. Eleven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $38.38.
Check Out Our Latest Stock Report on KDP
Insider Buying and Selling at Keurig Dr Pepper
In other Keurig Dr Pepper news, Director Robert James Gamgort sold 208,000 shares of the company's stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $32.90, for a total value of $6,843,200.00. Following the transaction, the director directly owned 2,292,169 shares of the company's stock, valued at $75,412,360.10. This represents a 8.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Mary Beth Denooyer sold 12,000 shares of the company's stock in a transaction that occurred on Thursday, July 17th. The shares were sold at an average price of $33.66, for a total value of $403,920.00. Following the sale, the insider directly owned 82,511 shares in the company, valued at approximately $2,777,320.26. This represents a 12.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 459,601 shares of company stock valued at $15,228,872 in the last three months. Corporate insiders own 1.00% of the company's stock.
Keurig Dr Pepper Company Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
See Also

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.